OCUL- Ocular Therapeutix, Inc.
Classified under Biotechnology (Health Care sector), OCUL's insider flows are most useful compared with peers in the same group.
Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 394.7K | $3.63M | - | |
| Other | 389.3K | $3.58M | - | |
| Other | 330.7K | $3.04M | - | |
| Other | 326.3K | $3.00M | - | |
| Other | 323.4K | $2.97M | - |
Activity
Buys and sells only
Transactions
10 filings · page 8
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 19, 2020 | Summer Road LLC47 | 10% Owner | Buy | 363,636 | $5.50 | $1,999,998.00 | +6.9% | |
| Mar 24, 2020 | Summer Road LLC47 | 10% Owner | Buy | 109,100 | $4.71 | $514,198.43 | +0.7% | |
| Mar 19, 2020 | Summer Road LLC47 | 10% Owner | Buy | 385,838 | $4.62 | $1,783,423.80 | +3.9% | |
| Mar 17, 2020 | Summer Road LLC47 | 10% Owner | Buy | 955,062 | $4.55 | $4,346,089.81 | +7.9% | |
| Jan 2, 2020 | Opaleye Management Inc.60 | 10% Owner | Buy | 15,000 | $3.90 | $58,507.50 | +0.3% | |
| Dec 30, 2019 | Opaleye Management Inc.60 | 10% Owner | Buy | 20,000 | $3.97 | $79,410.00 | +0.4% | |
| Jun 14, 2019 | Notman Donald | Chief Financial Officer | Buy | 2,500 | $4.33 | $10,825.00 | +11.6% | |
| Jun 14, 2019 | Williams Leslie J. | Director | Buy | 4,500 | $4.40 | $19,800.00 | New | |
| Jun 7, 2019 | Sawhney Amarpreet | Chairman Of The Board | Buy | 124,468 | $2.92 | $362,913.36 | +6.5% | |
| Jun 6, 2019 | Mattessich Antony C.47 | President &CEO | Buy | 40,000 | $2.81 | $112,400.00 | +69.1% |